G. Nabel

Alternative mechanisms for activation of human immunodeficiency virus enhancer in T cells.

D. Baltimore, G. Nabel, D. Knipe, 1988, Science.

Tumor necrosis factor receptor expression and signal transduction in HIV‐I-infected cells

G. Nabel, K. Leung, T. Folks, 1993, AIDS.

Immunotherapy for cancer by direct gene transfer into tumors.

E. Nabel, A. Chang, B. Fox, 1994, Human gene therapy.

Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes.

E. Nabel, A. Chang, G. Nabel, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Nonviral and viral delivery of a human immunodeficiency virus protective gene into primary human T cells.

M J Sheehy, Z. Yang, N. Yang, 1994, Proceedings of the National Academy of Sciences of the United States of America.

Regulated expression of a dominant negative form of Rev improves resistance to HIV replication in T cells.

Z. Yang, G. Nabel, C. Woffendin, 1994, Gene therapy.

A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription

G. Nabel, Z. Li, Gary J. Nabel, 1997, Molecular and cellular biology.

Differential regulation of NF-kappaB2(p100) processing and control by amino-terminal sequences

G. Nabel, Jonathan C. Betts, J. Betts, 1996, Molecular and cellular biology.

Isolation of a cDNA clone encoding a zinc finger protein highly expressed in T-leukemia lines.

G. Nabel, L. Turka, B. Wu, 1992, Blood.

The proto-oncogene bcl-3 encodes an I kappa B protein.

G. Nabel, I. Verma, C. Duckett, 1992, Genes & development.